Pau Sancho‐Bru

This study uses single-cell multiomics to trace clonal and phenotypic dynamics in hepatoblastoma after cisplatin treatment, identifying a plasticity-proliferation axis driven by BIRC5.

This study develops patient-derived liver biopsy organoids to model alcohol-associated liver disease and identifies disease-specific features and therapeutic responses.

This study maps the differentiation trajectory of iPSCs to hepatic stellate cells, identifying RORA as a key regulator of metabolic reprogramming and fibrosis.